Gliclazid retard Zentiva 30 mg, Retardtabletten - 30 Swissmedic Key 58740005 Registration Holder Helvepharm AG Name Gliclazid retard Zentiva 30 mg, Retardtabletten Date of registration 15.10.2008 Original/Generic Generic Introduction of Sequence 15.10.2008 ATC-Classification Gliclazide (A10BB09) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.06.20. Show package size 30 Index Therapeuticus (Swissmedic) 07.06.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 3.09 Limitation Yes Limitation text
Deductible 10 % Consumer price 12.60 Feedback FB Daily cost GTIN 7680587400054 Medication Code Synthetika Pharmacode Disponibility
Composition gliclazidum 30 mg, hypromellosum, calcii carbonas, lactosum monohydricum 73.5 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Gliclazide 30 mg
BAG: Active Agent Dose Gliclazide 30 mg
Inactive agents Dose Calcium Carbonate Hypromellosum Lactose Monohydrate 73.5 mg Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 08.01.2026
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
